✦ LIBER ✦

Long term outcome of bosentan treatment in primary pulmonary hypertension (PPH) and pulmonary arterial hypertension associated with the scleroderma spectrum of diseases (PAH-SSD)

✍ Scribed by R.E Girgis; S.C Mathai; J.A Krishnan; F.M Wigley; P.M Hassoun

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-Term Outcome of Bosentan Treatment

✍ Reda E. Girgis; Stephen C. Mathai; Jerry A. Krishnan; Fredrick M. Wigley; Paul M 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 155 KB

Long-term outcome and effects of oral bo

✍ Hsao-Hsun Hsu; Jin-Shing Chen; Robert J. Chen; Wen-Je Ko; Shuenn-Wen Kuo; En-Tin 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 221 KB

Survival in pulmonary hypertension assoc

✍ Stephen C. Mathai; Laura K. Hummers; Hunter C. Champion; Fredrick M. Wigley; Ari 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB 👁 3 views

Short-term drug interaction of bosentan

✍ Miyakawa, Sachiko; Tanaka, Shimako; Goto, Takahiro; Uchida, Shinya; Takeuchi, Ka 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Long-term effect of bosentan in adults v

✍ Rosa Laura E. van Loon; Elke S. Hoendermis; Marielle G.J. Duffels; Anton Vonk-No 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 472 KB

PROLONGED BENEFICIAL EFFECT OF BOSENTAN

✍ Mark J. Schuuring; Jeroen C. Vis; Marielle G. Duffels; Pepijn Mulder; Rianne De 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 240 KB